• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Quality of stroke guidelines in low- and middle-income countries: a systematic review
CONCLUSION: Guidelines on stroke in low- and middle-income countries need to be developed in conjunction with a wider category of health-care providers and stakeholders, with a full spectrum of translatable, context-appropriate interventions.PMID:34475601 | PMC:PMC8381090 | DOI:10.2471/BLT.21.285845
Source: Bulletin of the World Health Organization - September 3, 2021 Category: International Medicine & Public Health Authors: Joseph Yaria Artyom Gil Akintomiwa Makanjuola Richard Oguntoye J Jaime Miranda Maria Lazo-Porras Puhong Zhang Xuanchen Tao Jhon Álvarez Ahlgren Antonio Bernabe-Ortiz Miguel Moscoso-Porras German Malaga Irina Svyato Morenike Osundina Camila Gianella Olami Source Type: research

Prevalence of stroke in adults aged 40 to 79 years in Germany : Results of the German Health Interview and Examination Survey for Adults (DEGS1).
Abstract In the German Health Interview and Examination Survey (DEGS1), data on the prevalence of physician-diagnosed stroke were collected from 2008 to 2011 in a representative population-based sample of 5,901 adults aged 40-79 years. The stroke prevalence in DEGS1 was compared with prevalence estimates from the German National Health Interview and Examination Survey 1998 (GNHIES98). The lifetime prevalence of stroke in adults aged 40-79 years is 2.9 % (women: 2.5 %; men: 3.3 %). In both sexes, the prevalence increases continuously with age, up to 6.3 % in women and 8.1 % in men 70-79 years old. More...
Source: Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz - May 1, 2013 Category: Global & Universal Authors: Busch MA, Schienkiewitz A, Nowossadeck E, Gößwald A Tags: Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz Source Type: research

Fast treatment via mobile stroke unit reduced survivor disability
(American Heart Association) Stroke patients were more likely to get clot-busting treatment and received it faster if treatment started in a mobile stroke unit, an ambulance specially equipped to provide treatment.Those treated in a mobile stroke unit had less post-stroke disability, a German study found.
Source: EurekAlert! - Medicine and Health - February 20, 2020 Category: International Medicine & Public Health Source Type: news

Psychometric properties of the short form of the Stroke Impact Scale in German-speaking stroke survivors
The short form of the Stroke Impact Scale (SF-SIS) consists of eight questions and provides an overall index of health-related quality of life after stroke. The goal of the study was the evaluation of construc...
Source: Health and Quality of Life Outcomes - July 31, 2021 Category: International Medicine & Public Health Authors: Anna Coppers, Jens Carsten M öller and Detlef Marks Tags: Research Source Type: research

Effects of Improved Detection And Treatment of Atrial Fibrillation On Burden of Disease Caused By Stroke In Germany
Atrial fibrillation (AF) is a major risk factor for stroke with a prevalence of 1-2% of the general population. Patients with non-valvular AF show a 4 to5 times higher risk of stroke. According to a German registry study, AF goes undetected in one third of affected patients. Even if correctly diagnosed, AF is not always treated with oral anti-coagulants (OAC) according to treatment guidelines. For Germany, the estimated proportion of patients actually treated with OAC among all eligible AF-patients ranges from 38% to 83%.
Source: Value in Health - October 1, 2017 Category: International Medicine & Public Health Authors: H Nolting, B Deckenbach, K Zich Source Type: research

Costs of treating cardiovascular events in Germany: a systematic literature review
Conclusion MI, unstable angina, HF, stroke and PAD have a high financial impact on the German health care system. Treatment costs of these diseases are mostly incurred during the acute phase of events and tend to decrease over time. Hospitalization and rehabilitation costs were two major cost drivers. Medication costs was one of the smallest cost component reported.
Source: Health Economics Review - September 23, 2015 Category: Global & Universal Source Type: research

Long-Term Health Benefits of Treating Non-Valvular Atrial Fibrillation with Apixaban Versus Vitamin K Antagonists In Germany: A Population-Based Modelling Study
Patients with non-valvular atrial fibrillation (NVAF) are five times more likely to suffer a stroke, resulting in enormous personal, social and economic costs. For more than 50 years, vitamin K antagonists (VKAs) have been the primary medication for stroke prevention. Nevertheless, VKA therapy requires frequent monitoring, is limited by a narrow therapeutic window and is associated with an increased risk of bleeding. Apixaban, a non-vitamin K oral anticoagulant (NOAC), has shown superior efficacy and reduced risk of major bleeding compared to VKA in the ARISTOTLE trial.
Source: Value in Health - October 1, 2017 Category: International Medicine & Public Health Authors: M Mueller, S Himmler, E Basic, E Hradetzky Source Type: research

A cost-effectiveness analysis model of Preventicus atrial fibrillation screening from the point of view of statutory health insurance in Germany
ConclusionsThe modelling demonstrates the health benefits and economic effects of an implementation of a systematic screening on AF with “Preventicus Heartbeats”, given the perspective of the German payer, the statutory health care system.
Source: Health Economics Review - June 8, 2020 Category: International Medicine & Public Health Source Type: research

Novel PET tracer detects small blood clots
(Society of Nuclear Medicine) Blood clots in veins and arteries can lead to heart attack, stroke, and pulmonary embolism, which are major causes of mortality. In the featured article of The Journal of Nuclear Medicine's July 2017 issue, German researchers show that targeting GPIIb/IIIa receptors, the key receptor involved in platelet clumping, with a fluorine-18 labeled ligand is a promising approach for diagnostic imaging.
Source: EurekAlert! - Medicine and Health - July 6, 2017 Category: International Medicine & Public Health Source Type: news

Pages: 1  2  3  4  5  6  7